Re-assessing COPD Management: What are the Opportunities to Improve Patient Outcomes?

C

Exacerbations and Real-World Outcomes Among Patients With COPD Receiving Single Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate

By Charlie Strange
2,782 views
February 14, 2024
Comments 1
Login to view comments. Click here to Login
19:25

LAMA, LABA, ICS, PDE4i, Triple, Dual, Double: Unraveling the Pharmac…

Temple Lung Center

M. Dransfield

791 views
28:24

COPD: Current and Emerging Management Strategies

Brigham and Women's Hospital

C. P. Hersh

3.1K views
09:48

COPD: Dual Vs. Triple Therapy

Stephen Brunton

3.3K views
22:24

ERS 2023 Insights: Pharmacological Treatment and Current Controversi…

ERS 2023 Insights

K. Kostikas

1.3K views
15:05

ERS 2023 Insights: Novel Immune Mechanisms of COPD Initiation and Pr…

ERS 2023 Insights

F. Polverino

567 views
13:43

CHEST 2023 Insights: COPD - New Diagnostic Paradigm

CHEST 2023 Insights

B. Make

1.8K views
11:10

Therapeutic Options for Acute COPD Exacerbations: GOLD 2024 Guidelin…

Sami Hossri

2.2K views